Related Experiment Videos
Interferon responses in schizophrenia and major depressive disorders
A D Inglot1, J Leszek, E Piasecki
1Laboratory of Virology, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw.
Biological Psychiatry
|April 1, 1994
Summary
Psychiatric patients, particularly those with schizophrenia, exhibit altered interferon (IFN) production. Specific IFN response patterns correlate with schizophrenia symptoms, suggesting underlying biological factors.
Area of Science:
- Immunology
- Neuroscience
- Psychiatry
Background:
- Interferon (IFN) production plays a role in immune response.
- Previous studies suggest potential immune dysregulation in psychiatric disorders.
Purpose of the Study:
- To investigate spontaneous and induced interferon production in psychiatric patients.
- To explore the relationship between IFN response patterns and specific psychiatric diagnoses, particularly schizophrenia.
- To identify potential factors in patient plasma that influence IFN production.
Main Methods:
- Whole blood cultures from 45 psychiatric inpatients (32 chronic schizophrenics, 13 severely depressed) and 65 normal controls were stimulated with various inducers (NDV, LPS, PHA+PMA).
- Interferon levels were measured.
- Plasma samples from schizophrenic patients were used to assess their effect on IFN production in normal leukocytes.
Main Results:
- Psychiatric patients showed significantly lower IFN production in response to viral (NDV) and bacterial (LPS) stimuli compared to controls.
- No difference in IFN response was observed for PHA+PMA stimulation.
- Chronic schizophrenics were categorized as high or low IFN responders; high responders had positive symptoms, while low responders had negative symptoms.
- Schizophrenic plasma transferred hypersensitivity to IFN inducers to normal leukocytes.
Conclusions:
- Altered IFN production is associated with psychiatric disorders, especially schizophrenia.
- Specific IFN response patterns correlate with symptom presentation in schizophrenia.
- Factors in schizophrenic plasma, possibly opioid peptides, may modulate cytokine production, including interferons.